Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07004842

Alternative Carer Respite: A Study on Its Effectiveness and Potential Mechanism

Alternative Carer Respite: A Study on Its Effectiveness and Potential Mechanisms

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to examine the effectiveness of alternative carer respite in meeting the unique needs of older adults without children or with limited contact with their children in Hong Kong. Caregivers are assessed before and after the intervention, and three months after the end of intervention on their physical health, mental well-being, social engagement, and overall satisfaction.

Detailed description

All participants will provide informed consent at the time of enrolment. Both caregivers and their care recipients will complete an assessment. Caregivers are screened for their physical health, mental well-being, social engagement, and overall satisfaction. Care recipients are screened using InterRAI for their physical functions. Caregivers will receive a maximal of 48 hours of respite service within 6 month. Alternative caregivers will provide in-home elderly-sitting service so that the caregivers can have some private time for themselves. At the end of the service period, caregivers and care recipients will complete the assessment again to measure the changes of their physical and mental health. All participants will be contacted again for follow-up assessment 3 months after the completion of service.

Conditions

Interventions

TypeNameDescription
OTHER48 hr Respite ServiceCaregivers will be provided with 48 hours of respite service within 6 months. Trained alternative caregivers will provide elderly-sitting service at their home, allowing the caregivers to have their personal time.

Timeline

Start date
2023-12-01
Primary completion
2025-11-30
Completion
2025-11-30
First posted
2025-06-04
Last updated
2025-06-04

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT07004842. Inclusion in this directory is not an endorsement.